Drawing for AXION

USPTO serial 86789673

AXION

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
LIEBL, ALEXANDRA
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with AXION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

AnneMarie Kaiser

ANNEMARIE KAISER Edwards Lifesciences Corporation1 Edwards WayIrvine, CA 92614-5688UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
010Medical and surgical apparatus and instruments for use in cardiovascular proceduresABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 29, 2016MAB5ABANDONMENT NOTICE MAILED - AFTER PUBLICATION—
Mar 29, 2016ABN5ABANDONMENT - AFTER PUBLICATION—
Mar 24, 2016EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Feb 24, 2016ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Feb 2, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 13, 2016NPUBNOTICE OF PUBLICATION—
Dec 14, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 11, 2015DOCKASSIGNED TO EXAMINER—
Oct 20, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 19, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance